logo
Backyard hockey rinks are a fixture of Canadian winters. Can they last with climate change?

Backyard hockey rinks are a fixture of Canadian winters. Can they last with climate change?

CBC21-02-2025
Social Sharing
Skates and hockey sticks on backyard rinks are the definitive sound of winter for many Canadians.
But Robert McLeman, a professor of geography and environmental studies at Ontario's Wilfrid Laurier University, warns that climate change is having a serious effect on this traditional pastime.
"In the old days when I was a kid, you just flooded straight onto the snow that was packed into the ground," McLeman said.
"But the ground doesn't freeze as solid as it used to. If you get one of these little thaw events in the middle of January or February, all of your rink just drains away and you have to start from scratch."
And while much of the focus is on the effects on polar bears and mountain glaciers, watching the effect climate change has on more familiar activities, such as family rinks, might spur more action from communities, he said.
McLeman is the director of a website called RinkWatch.org, which began in 2012, where people can pin the location of their backyard rinks on a map and help monitor the impacts of climate change.
On this map, more than 1,400 rinks are listed across the world, which are updated to keep track of ever-changing ice conditions. About 50 of those are in New Brunswick, spreading from Edmundston and Bathurst to Saint John, Sackville and Shediac.
RinkWatch describes itself as "a citizen science research initiative" that asks people to '"help monitor winter weather conditions and study the long-term impacts of climate change."
As users update their rink's ice conditions on the website throughout the year, scientists can analyze the changing winter conditions across Canada with verifiable evidence.
McLeman says that conditions have caused the creation of outdoor rinks to change drastically. Now, people are "investing in chillers and building… artificial refrigerated rinks in their backyard in barns," or putting plastic liners down on the ground before flooding it for protection.
Backyard rinks are a warm memory for many families, he says. "It's used by every generation from grandparents to little ones. Just have a place to go in the dead of winter when the days are short, nights are long and, you know, get the kids out of the basement off those game consoles and out playing with their friends."
He often hears people talking about how different winter was in the past and wants them to know that it is not just their imagination.
"When you think about it, you know, the last few winters have sort of tricked us into thinking that winter is just this sort of mild, slushy, stormy thing. But the winter we're having right now, if you go back to the 1970s, '80s, '90s, this is a pretty typical winter."
The backyard rink drives it home and also shows just how climate change impacts daily life. It is causing the potential loss of something that so many hold so close to their hearts. At the current rate of change, winter will be far milder very soon, McLeman warns.
"We're going to have snow that melts really quickly, freezing rain, slush and so on. So we won't be able to play outside in winter anymore, at least not as much as we used to, and that's a shame both for us and for our kids."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Canada strengthens global leadership in medical isotope production
Canada strengthens global leadership in medical isotope production

Cision Canada

time2 days ago

  • Cision Canada

Canada strengthens global leadership in medical isotope production

Government achieves new milestone in partnership with Bruce Power and First Nation on producing cancer-fighting medical isotopes TIVERTON, ON, Aug. 19, 2025 /CNW/ - The Government of Canada is investing in Canada's nuclear, biomanufacturing and life sciences sectors to strengthen Canada's position as a global leader in nuclear medicine innovation. These investments are bolstering domestic supply chains to ensure Canadians have access to vital diagnostics and therapeutic treatments. Today, the Honourable Tim Hodgson, Minister of Energy and Natural Resources, on behalf of the Honourable Mélanie Joly, Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions, announced the next phase of an ambitious medical isotope production project at the Bruce Power nuclear plant facility in Tiverton, Ontario. This next phase will see the installation of a second isotope production system (IPS) at Bruce Power's CANDU Unit 6 reactor, which will allow for a significant increase in the plant's ability to produce the medical isotope lutetium-177, used in targeted cancer therapies. The project is receiving funding through the Canadian Medical Isotope Ecosystem (CMIE), which was established in 2023 with an investment of up to $35 million over five years through the Government of Canada's Strategic Innovation Fund, with the goal of spurring the development and commercialization of medical isotopes and radiopharmaceuticals in Canada. The CMIE directs project funding that supports collaborative research and development initiatives focused on medical isotopes, with the goal of creating and commercializing innovative treatments in the health care sector while also securing the domestic production of medical isotopes. Since March 2020, the government has invested more than $2.5 billion in 43 projects in the biomanufacturing, vaccine and therapeutics ecosystem. The Government of Canada's support for the CMIE is a critical aspect of this investment, bolstering Canada's historical leadership in medical isotope production. The market for medical isotopes worldwide is increasing and is expected to reach up to US$33 billion by 2031. The project expansion announced today helps to ensure that Canada will maintain a steady domestic supply as well as sustain and expand export capabilities to global markets. With its innovative IPS technology, Bruce Power is the first commercial nuclear reactor in the world to produce lutetium-177, supplying large quantities of life-saving medical isotopes while simultaneously generating safe, clean and reliable electricity. This helps advance Canada's role as both an energy and a medical isotope superpower. The Government of Canada is proud to partner with the Saugeen Ojibway Nation (SON) and Bruce Power to produce, advance and market new medical isotopes in support of the global fight against cancer. The project contributes significantly to reconciliation within the SON territory. Quotes "Medical isotopes are a powerful tool in the diagnosis and treatment of cancer. Through the government's investment in the CMIE, as well as its partnership with Bruce Power and the Saugeen Ojibway Nation, we are ensuring that Canadians have access to a critical medical technology. This next phase of Bruce Power's capacity expansion strengthens Canada's role as a global leader in medical isotope production while enhancing the quality of care available to every Canadian." – The Honourable Mélanie Joly, Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions "Canada is proud to be at the forefront of innovation in both clean energy and life-saving medical technology. By supporting Bruce Power's isotope production system, we are ensuring a stable supply of cancer-fighting isotopes for patients at home and around the world, while creating highly skilled jobs and an attractive investment ecosystem and strengthening Canada's status as a Tier 1 nuclear nation." – The Honourable Tim Hodgson, Minister of Energy and Natural Resources "Canada is proud to support research and development on medical isotopes, which are critical for diagnosing and treating a wide range of diseases, such as cancer and heart disease. With this investment, we will continue to play a leading role in the global supply of medical isotopes and drive the creation of innovative health care treatments for Canadians." – The Honourable Marjorie Michel, Minister of Health "Ontario's nuclear advantage is about powering our economy by harnessing Canadian technology, built by Canadian workers. Almost one-third of Ontario's power is generated at Bruce, and we are also proud to expand the production of life-saving isotopes at this world-class generating station. Ontario has an ambitious plan to double medical isotope production by 2030, driven in part by the expansion at Unit 6, enabling 24/7 production of cancer-fighting isotopes for Canadians and people around the world." – The Honourable Stephen Lecce, Ontario Minister of Energy and Mines "This investment is a crucial step toward meeting Ontario's goal of doubling medical isotope production by 2030. The CMIE is proud to support this initiative and help ensure Canada's medical isotope ecosystem is strong and resilient and remains a global leader in the advancement of cancer care." – Dr. Holly Bilton, Chair of the Canadian Medical Isotope Ecosystem Quick facts The Canadian Medical Isotope Ecosystem (CMIE) is a pan-Canadian initiative led by the Centre for Probe Development and Commercialization and TRIUMF Innovations, not-for-profit corporations specializing in radiopharmaceutical products and the commercialization of particle acceleration, respectively. Supporting the medical isotopes sector through the CMIE will improve Canadian expertise in medical isotopes and make Canada an attractive hub for investment in this sector, contributing to Canada's position as a global leader in the field. Medical isotopes are used by medical professionals to diagnose and treat health conditions such as heart disease and cancer. Medical isotopes are produced using two overarching technologies: nuclear reactors and particle accelerators. There are currently global constraints on the supply of medical isotopes, and the CMIE will ensure that Canada remains at the forefront of nuclear medicine innovation. Lutetium-177 is a medical isotope used in targeted radionuclide therapy for certain cancers, specifically neuroendocrine tumours and prostate cancer. Radionuclide therapies show incredible promise for cancer treatment due to their ability to deliver targeted doses of radiation directly to cancer cells while minimizing potential side effects on healthy cells. By producing these critical resources domestically, Canada will be positioned to take advantage of the ever-growing global market for medical isotopes. Globally, more than 40 million procedures are performed each year using medical isotopes for both diagnostic and therapeutic purposes. Stay connected Find more services and information on the Innovation, Science and Economic Development Canada website. SOURCE Innovation, Science and Economic Development Canada

ROBINSON: Canadians with glioblastoma enduring cruel provincial red tape
ROBINSON: Canadians with glioblastoma enduring cruel provincial red tape

Toronto Sun

time2 days ago

  • Toronto Sun

ROBINSON: Canadians with glioblastoma enduring cruel provincial red tape

For the 1,600 Canadians who will receive glioblastoma diagnoses this year alone, Optune could offer hope to some of them to extend their lives Walter Robinson, is a former life sciences executive and member of the Board of Directors of the Canadian Organization for Rare Disorders (CORD). Almost 30 years ago my father succumbed to glioblastoma multiforme (GBM), one of the most aggressive and deadly forms of brain cancer. From the stroke that led to his diagnosis to surgery, radiation, and ultimately his death, he lived a mere 66 days. He died at the too-young age of 66. This advertisement has not loaded yet, but your article continues below. THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account. Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on. Enjoy insights and behind-the-scenes analysis from our award-winning journalists. Support local journalists and the next generation of journalists. Daily puzzles including the New York Times Crossword. SUBSCRIBE TO UNLOCK MORE ARTICLES Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account. Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on. Enjoy insights and behind-the-scenes analysis from our award-winning journalists. Support local journalists and the next generation of journalists. Daily puzzles including the New York Times Crossword. REGISTER / SIGN IN TO UNLOCK MORE ARTICLES Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account. Share your thoughts and join the conversation in the comments. Enjoy additional articles per month. Get email updates from your favourite authors. THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK. Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account Share your thoughts and join the conversation in the comments Enjoy additional articles per month Get email updates from your favourite authors Don't have an account? Create Account Today there is an approved treatment, but not one provincial government has given patients access. Roughly 1,600 Canadians are diagnosed with GBM each year. When my dad died in December 1996, survival rates were 5%, today, 6%. Median survival is just over a year, and only one in twenty patients will live beyond five years. Despite aggressive treatment – typically a combination of surgery, radiation, and chemotherapy — GBM often returns. It insidiously invades brain tissue, making full surgical removal impossible. The blood-brain barrier prevents 99% of small- and large-molecule therapies used for other cancers from reaching a GBM tumour. Worse, GBM evades treatment and can build immunity to conventional chemotherapy, frustrating researchers, clinicians, patients, and their families. Your noon-hour look at what's happening in Toronto and beyond. By signing up you consent to receive the above newsletter from Postmedia Network Inc. Please try again This advertisement has not loaded yet, but your article continues below. For decades, the toolbox available to patients and clinicians to fight back has been almost empty. Today, clinical trials are underway on nanotech-delivered treatments that evade the blood-brain barrier fortress. Other countries are increasing survival rates with combination drug therapies. And material science innovation has given us a surgically implanted dissolvable wafer to better treat these tumours. In addition, a new therapy, Optune – also known as Tumor Treating Fields (TTFields), offers a unique and non-invasive treatment option. When combined with chemotherapy, Optune has been shown to significantly extend survival by months, and in some cases, doubled life expectancy. This is a major medical advancement. This advertisement has not loaded yet, but your article continues below. But, sadly, not a single province has committed to funding it, despite its approval by Health Canada in 2022 and a recommendation for public funding by Canada's Drug Agency in early 2024. For Canadians with glioblastoma, this is cruel provincial red tape. Canadians are dying on waiting lists and cannot get access to Health Canada-approved medical treatments. It is exactly the kind of barrier that undermines faith in our public health system and in the faceless, unaccountable officials who administer it. Politicians often speak about their commitment to accelerate access to life-saving therapies for Canadians. Heck, the premiers have repeatedly pledged to fix this issue, without any resulting action or access. Meanwhile, GBM patients in other countries are living longer with Optune. This advertisement has not loaded yet, but your article continues below. The federal government has already allocated $1.4 billion, and signed bilateral deals with all provinces, to fund treatments for rare diseases. By every definition, GBM is a rare disease. And Optune is a textbook case of what this funding is supposed to support. It has cleared every scientific and regulatory hurdle in Canada but remains out of reach to patients. My father died long-before this innovation came along. But for the 1,600 Canadians who will receive glioblastoma diagnoses this year alone, Optune could offer hope to some of them to extend their lives. Our provincial governments have the power to give them a few more priceless months with their loved ones. A chance to walk a daughter down the aisle or share one more Christmas morning with their son. The money is already set aside. The approvals have been granted. There is no excuse to wait another day, another hour, or another minute. — Walter Robinson, is a former life sciences executive and member of the Board of Directors of the Canadian Organization for Rare Disorders (CORD). Toronto Blue Jays Canada World Ontario Sunshine Girls

Critics of forest fire restrictions can't see the truth for the burning trees
Critics of forest fire restrictions can't see the truth for the burning trees

Toronto Star

time3 days ago

  • Toronto Star

Critics of forest fire restrictions can't see the truth for the burning trees

Wildfires are currently raging across Canada, from the Pacific shores of Vancouver Island to the eastern expanses of Newfoundland, Nova Scotia and New Brunswick. So stark is the threat in Atlantic Canada that governments there have temporarily banned many outdoor activities due to the heightened risk — prompting some to claim this represents an encroachment on Canadians' freedom. But with parched forests and conditions ripe for disaster, the recent bans on outdoor leisure activities in Nova Scotia and New Brunswick are not government overreach; they are essential measures to safeguard lives and protect vital ecosystems.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store